Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data.
Robb AS, Carson WH, Nyilas M, Ali M, Forbes RA, Iwamoto T, Assunção-Talbott S, Whitehead R, Pikalov A. Robb AS, et al. Among authors: iwamoto t. J Child Adolesc Psychopharmacol. 2010 Feb;20(1):33-8. doi: 10.1089/cap.2008.0163. J Child Adolesc Psychopharmacol. 2010. PMID: 20166794 Clinical Trial.
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
Tandon R, Marcus RN, Stock EG, Riera LC, Kostic D, Pans M, McQuade RD, Nyilas M, Iwamoto T, Crandall DT. Tandon R, et al. Among authors: iwamoto t. Schizophr Res. 2006 May;84(1):77-89. doi: 10.1016/j.schres.2005.12.857. Epub 2006 Feb 14. Schizophr Res. 2006. PMID: 16483745 Clinical Trial.
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Andrezina R, et al. Among authors: iwamoto t. Psychopharmacology (Berl). 2006 Oct;188(3):281-92. doi: 10.1007/s00213-006-0541-x. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953381 Clinical Trial.
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
Findling RL, Kauffman R, Sallee FR, Salazar DE, Sahasrabudhe V, Kollia G, Kornhauser DM, Vachharajani NN, Assuncao-Talbott S, Mallikaarjun S, Iwamoto T, McQuade RD, Boulton DW, Blumer J. Findling RL, et al. Among authors: iwamoto t. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):431-9. doi: 10.1089/cap.2008.0111. J Child Adolesc Psychopharmacol. 2009. PMID: 19702495
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T; Aripiprazole Study Group. Sachs G, et al. Among authors: iwamoto t. J Psychopharmacol. 2006 Jul;20(4):536-46. doi: 10.1177/0269881106059693. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401666 Clinical Trial.
1,991 results